Nurse Practitioner in Keshena, WI Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Sue C Weso, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: W3275 Wolf River Road, Keshena, WI 54135 Phone: 715-799-3361 Fax: 715-799-3099 |
Sarah Harkey, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: W3275 Wolf River Road, Keshena, WI 54135 Phone: 715-799-3361 |
Stephanie Diane Hurda, APNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: W3275 Wolf River Dr, Keshena, WI 54135 Phone: 715-304-9830 |
Jacqueline Susan Moe, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W3275 Wolf River Dr, Keshena, WI 54135 Phone: 715-799-3361 |
Elizabeth A Radtke-petri, N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: W3275 Wolf River Road, Keshena, WI 54135 Phone: 715-799-3361 Fax: 715-799-3099 |
News Archive
AstraZeneca and UT Southwestern agree to a three-year collaboration to combat psychiatric illness
Depression is one of the leading causes of disability in the United States, affecting approximately 14.8 million adults or about 6.7 percent of the population age 18 and older in a given year(1).
Researchers use magic-angle-spinning NMR to unveil structure of CAP-Gly protein
A latticework of tiny tubes called microtubules gives your cells their shape and also acts like a railroad track that essential proteins travel on. But if there is a glitch in the connection between train and track, diseases can occur.
Studies support clinical use of antidepressants for treatment of postoperative pain
Antidepressants are known to provide effective pain relief for various chronic pain conditions; however, the jury is still out on their use in treating the millions of patients who suffer from acute or chronic pain following surgery.
RIT professor receives federal award for research to help combat threat of antibiotic-resistant bacteria
A Rochester Institute of Technology professor has received a federal award for research that could help in the critical battle to develop new drugs to combat the drastic rise in the number of antibiotic-resistant bacteria.
Inspiration submits IB1001 BLA with FDA for treatment of hemophilia B
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
› Verified 2 days ago